Baxter Plans New Kidney Care Business for Growth and Innovation
In 12-18 months, Baxter plans to spin off its Renal Care and Acute Therapies businesses into a separate publicly traded company.
Read the full article » | Posted 01-10-2023
Related Articles
- Fresenius Medical Care named Shervin Korangy as CEO Posted 10-22-2026
- Aligning Clinical Excellence with Health System Goals Through PD in Value-Based Models Posted 10-22-2026
- Update on National Institutes of Health websites Posted 10-22-2026
- What to Know About the American Society of Nephrology Kidney Week Posted 10-22-2026